Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
FDA
Nov 18, 2023, 16:36 |
Career
Applications for the February 2024 FDA Oncology - ASCO Fellows Day Workshop are now being accepted until Nov 27! - FDA Oncology
FDA Oncology announced on their X/Twitter: "Applications for the February 2024 FDA Oncology-ASCO Fellows Day…
Nov 17, 2023, 17:53 |
Blog
Lisa A. Lacasse: American Cancer Society Cancer Action Network joined 79 other organizations supporting FDA rules to stop the sale of menthol cigarettes and all flavored cigars
Oct 31, 2023, 15:38 |
Insight
Susan Pandya: U.S. FDA approval of our targeted therapy underscores the efforts of our exceptional clinical research team
Susan Pandya, Vice President of Clinical Development and Global Head of Cancer Metabolism at Servier…
Oct 18, 2023, 16:43 |
Drugs
U.S. FDA approved pembrolizumab for NSCLC as single-agent for adjuvant and in combination with chemo for neoadjuvant settings - American Association for Cancer Research
American Association for Cancer Research recently shared on its Twitter page: "Today, the U.S. FDA…
Oct 15, 2023, 18:52 |
Blog
Ricardo Garcia: Dovitinib has received Orphan Drug Designation (ODD) from the FDA for osteosarcoma.
Ricardo Garcia, CEO and founder of Oncoheroes Biosciences, posted on his LinkedIn page: "Here we…
Oct 14, 2023, 17:49 |
Drugs
Chris Boshoff: the U.S. FDA approved our targeted combination therapy for the treatment of adult patients with BRAF V600E-mutant metastatic non-small cell lung cancer (NSCLC).
Oct 13, 2023, 17:37 |
Blog
Thor Halfdanarson: Dear friends, sincerest thanks for the trust and thanks to Pamela Kunz for model leadership.
Thor Halfdanarson, Professor of Oncology at Mayo Clinic, shared a post by Julie Hallet on…
Oct 13, 2023, 17:10 |
Drugs
Rami Manochakian: FDA Oncology approves the combination of Encorafenib and Binimetinib for Patients with metastatic Non-Small cell Lung Cancer with a BRAF V600E mutation.
Oct 13, 2023, 12:29 |
Blog
Edward Cliff: I’m delighted to share that I was selected to be an FDA American Association of Cancer Research Oncology Education Fellow for 2023-2024.
Quoting Edward Cliff, Postdoctoral Research Fellow at Harvard Medical School, on LinkedIn: “I’m delighted to…
Oct 9, 2023, 18:53 |
Career
Daniel E. Spratt: It is a huge honor to be the 1st radonc as a full standing member on the FDAs ODAC (I am at least told).
Daniel E. Spratt, Chair of the Department of Radiation Oncology at University Hospitals Cleveland Medical…
22
23
24
25
26
All:
941
Posts:
231 - 240
ASTRO24: 15 Posts Not To Miss From Day 4
Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024
Paper Alert! Cutaneous Metastases in Thyroid Cancer: A Comprehensive Review of 136 Cases
ASTRO 24: 15 Posts Not to Miss From Day 3
Gavin Creel: Broadway Icon Dies After Battle with Rare Sarcoma at 48
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube